Serum NfL (Neurofilament Light Chain) Levels and Incident Stroke in Adults With Diabetes Mellitus
Authors:
- 1 July 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 50 (7) , 1669-1675
Abstract
Background and Purpose—: Effective stroke prevention depends on accurate stroke risk prediction. We determined the discriminative ability of NfL (neurofilament light chain) levels for distinguishing between adults with diabetes mellitus who develop incident stroke and those who remain stroke free during a 7-year follow-up period. Methods—: We performed a case-control study of participants selected from the previously completed ACCORD trial (Action to Control Cardiovascular Risk in Diabetes). Cases were all ACCORD subjects who were stroke free at enrollment and developed incident stroke during follow-up (n=113). Control subjects (n=250) were randomly selected ACCORD subjects who had no stroke events either before or after randomization. NfL was measured in baseline samples using Single Molecule Array technology (Quanterix). Results—: Baseline NfL levels were higher in stroke subjects, compared to controls, after adjusting for age, race, blood pressure, weight, and the Framingham Stroke Risk Score. Relative to the subjects in the lowest quintile of NfL levels, the hazard ratios of incident stroke for subjects in the second to fifth quintiles were 3.91 (1.45–10.53), 4.05 (1.52–10.79), 5.63 (2.16–14.66), and 9.75 (3.84–27.71), respectively, after adjusting for race and Framingham Stroke Risk Score. Incorporating NfL levels into a predictive score that already included race and Framingham Stroke Risk Score increased the score’s C statistic from 0.71 (95% CI, 0.66–0.77) to 0.78 (95% CI, 0.73–0.83), P <0.001. Older age, nonwhite race, higher systolic blood pressure, glomerular filtration rate <60, and higher hemoglobin A1C were independent predictors of serum NfL in this cohort but diastolic blood pressure, durations of hypertension or diabetes mellitus, and lipid levels were not. In total, cardiovascular disease risk factors explained 19.2% of the variability in baseline NfL levels. Conclusions—: Serum NfL levels predict incident stroke and add considerably to the discriminatory power of the Framingham Stroke Risk Score in a cohort of middle-aged and older adults with diabetes mellitus.Keywords
This publication has 21 references indexed in Scilit:
- Serum neurofilament light chain in patients with acute cerebrovascular eventsEuropean Journal of Neurology, 2018
- Seeking the “holy grail” of biomarkers to improve stroke risk prediction of clinical scoresNeurology, 2016
- Silent Brain Infarction and Risk of Future StrokeStroke, 2016
- Neurofilament light chainNeurology, 2015
- Biomarkers of mild traumatic brain injury in cerebrospinal fluid and bloodNature Reviews Neurology, 2013
- Silent Brain Infarction – A Review of Recent ObservationsInternational Journal of Stroke, 2012
- Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and MortalityStroke, 2010
- Silent Brain Infarction and Subcortical White Matter Lesions Increase the Risk of Stroke and Mortality: A Prospective Cohort StudyJournal of Stroke and Cerebrovascular Diseases, 2006
- Silent MRI infarcts and the risk of future strokeNeurology, 2001
- Combining diagnostic test results to increase accuracyBiostatistics, 2000